Icon

RAZADYNE ER (nda021615)- (EQ 8MG BASE,EQ 16MG BASE,EQ 24MG BASE)

GALANTAMINE HYDROBROMIDE JANSSEN PHARMS
EQ 8MG BASE,EQ 16MG BASE,EQ 24MG BASE
Yes No
2019-Dec-20 Expired
None None
None No
RAZADYNE ® ER is a cholinesterase inhibitor indicated for the treatment of mild to moderate dementia of the Alzheimer’s type.
4 0 2
Total Other Developers 1
Drugs with Suitability No
EQ 8MG BASE ** ** Up - 2
EQ 16MG BASE ** ** Down - 2
EQ 24MG BASE ** ** Up - 2
NDA Sales Available Total Generic Sales Available
Yes 2
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** *** ***** *** ************** ********** ******* *********** ****** **. ****, *****, ***** ********* ** ***** *** ***** ****** *** ***** *** *** ******, ***** (***) ***
****** ********* ****** ********* ****** ******* *********** ****-***, ** **. ***/*, ***/*, ***/*, ***/* & ***/*, **** ** **** ***, *****, ***** ********** ****, *********, ********* ******, ************, ********* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.